ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. - Wikidata - awgldk - TriplyDB

ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.

ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.

http://www.wikidata.org/entity/Q38461021

about

Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma Anaplastic lymphoma kinase: signalling in development and disease Inflammatory myofibroblastic tumour of the gallbladder Intra-abdominal inflammatory myofibroblastic tumor: spontaneous regression Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitors Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib.Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor ALK protein expression in rhabdomyosarcomas.Inflammatory myofibroblastic tumour of the tonsil: case report and literature review.Absence of anaplastic lymphoma kinase translocations in signet ring cell carcinomas of the upper gastrointestinal tract.Pulmonary inflammatory myofibroblastic tumor versus IgG4-related inflammatory pseudotumor: differential diagnosis based on a case series.Sinonasal Inflammatory Myofibroblastic Tumor with Anaplastic Lymphoma Kinase 1 Rearrangement: Case Study and Literature Review ALK-rearrangements and testing methods in non-small cell lung cancer: a review Inflammatory myofibroblastic tumor of the thigh without bone involvement: a case report.Recurrent inflammatory myofibroblastic tumors harboring PIK3CA and KIT mutations.Inflammatory myofibroblastic tumor of the small bowel: a case report.New therapeutic targets in soft tissue sarcoma.ALK inhibitors in non-small cell lung cancer: crizotinib and beyond.Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.Inflammatory myofibroblastic tumour in a female urethra: A rare benign lesion that mimics malignancy.Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins.Inflammatory myofibroblastic tumour: report of a rare form with exclusive pleural involvement Maxillary sinus inflammatory myofibroblastic tumors: a review and case report.Inflammatory myofibroblastic tumors of the head and nec.Inflammatory myofibroblastic tumour of paranasal sinuses with fatal outcome: reactive lesion or tumour?ALK positive inflammatory myofibroblastic tumour of the pineal region Differential diagnosis of laryngeal spindle cell carcinoma and inflammatory myofibroblastic tumor--report of two cases with similar morphology.Abdominopelvic inflammatory myofibroblastic tumor that metastasized to the vertebrae and liver: A case report and review of the literature Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement Articular nodular fasciitis of the right shoulder joint: report of an unusual case with focus on immunohistochemical differential diagnosis STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature.Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population.Progressive tumefactive fibroinflammatory lesion of the infratemporal fossa treated by radiation therapy Inflammatory Myofibroblastic Tumor of the Liver: A Diagnostic Challenge.Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer.

P2860

Q21285042-974F3030-F92C-45A4-A040-4190928EAC6B Q24312329-B9ACB646-F5B1-4EC7-93C6-4F96F3D63F1C Q24802581-A05BE66C-FC9D-4D8D-A3B9-AD738BFB638B Q26853086-50A58728-91F2-4E17-A7D4-E3A3F6D586DF Q27001114-85DB906D-4887-4B75-9CD5-9226C267AB21 Q27310990-E46C046D-5F55-43A4-8289-8536866A8CE5 Q27851589-CD29687B-B44A-41B1-9D82-E7E4892D1277 Q27851671-97B955CA-8A84-4CE3-90B5-ED8834049456 Q27853012-1D4EE5A1-0F87-438B-B529-F259123B1780 Q27853092-296270B3-882F-4CDF-AC71-A32DD396F4F9 Q28214316-675D63D0-FDD7-46E6-B452-AEE7F66A37AA Q31116403-4766E25C-1844-46B4-ACF7-D13686CA5F15 Q33531356-9204576B-B6ED-4080-BD39-0087DCB3FDF3 Q33557250-D9DB6B2D-5E91-45B1-A159-325F85992FD4 Q33571326-790777E6-7304-4FD6-8BA6-36727DBA48D8 Q33676389-7B18A56F-71EF-4EA3-8401-3041448C7719 Q33776835-55EBC1CC-55D6-4C76-B43D-8C926702AAAA Q33965166-E3FF3217-31FA-414B-8DB3-6655BA60288C Q34028920-785012FD-BB2C-4C17-B892-37E5ED339DA8 Q34135000-A2BE59C5-1ABD-41B0-94DB-E05514A38D34 Q34267924-51A0A18F-E147-4D1A-81AC-EBAE335C2959 Q34431889-14816C1D-5BF4-4388-A564-746D98ED199A Q34450749-A848BB94-1F29-446A-AEFA-5EC1E3F28733 Q34602235-274AAF9B-D882-486B-8978-35A72DDA689D Q34624556-8494D6BD-B739-4C68-BE5D-E6F4CB9A5A3A Q34668858-3BEC273F-DFEE-4A95-9C12-EED328C21D65 Q35119723-7019791A-EB38-4D27-AF77-AC6FDA081386 Q35479102-6108DC30-9D61-491B-9912-76E62495D0D9 Q35587007-69D99A94-226C-437E-9692-B9EB5EB72B84 Q35588948-E8EFF946-E761-40CA-8EDA-DE6C0914DC3C Q35605292-84E4D3DC-4F06-40FE-8A8F-ABB6BFB98328 Q35642057-6B60036A-94D3-4180-8E22-D7CFE8D1F40C Q35738399-D7631009-4817-48ED-ADF7-495BC73AA38C Q35741241-56894129-2C74-4156-BA4E-D5D568E624B7 Q35741417-3DC56043-26A9-4F93-8B05-AEB5FFD44240 Q35754685-241CDE25-86E4-4DF5-A0C6-CF3B77362F0D Q35871758-3F25FA3E-8517-483F-A329-08454D0CC7ED Q35887363-D25FB025-49F7-47AE-9693-9B7D456B85D3 Q35905981-68BBFE5E-EBBB-4E6B-8B98-C72CA55976DA Q36092910-E6DB1587-334D-43EB-8C99-442823DC9542

P2860

ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.

http://www.wikidata.org/entity/Q38461021

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

ALK1 and p80 expression and ch ...... mmatory myofibroblastic tumor.

@en

type

label

ALK1 and p80 expression and ch ...... mmatory myofibroblastic tumor.

@en

prefLabel

ALK1 and p80 expression and ch ...... mmatory myofibroblastic tumor.

@en

P1433

Q38461021-D1B42DBB-BCA8-452E-9A64-CD5FD688B548

P1476

Q38461021-AF249A51-0609-4A81-99D1-F1319AFF1E7A

P2093

Q38461021-0FDDB8C7-D2FC-457A-B683-10B2501A88E3

Q38461021-A2D0786F-BD1D-496D-BA88-62FDC0D527DF

Q38461021-BFB5BAF7-72C8-4A19-BE63-2A176B50AA1C

Q38461021-EB128B00-E53E-48E1-A017-864BFFFD3CF3

Q38461021-F69BE340-0EE2-4371-9CA6-8EF3AA3729F1

P2860

Q38461021-1895A464-5E8A-4F53-B963-850B948D3911

Q38461021-71031498-3A1B-409C-857E-194F9ADBDA2D

Q38461021-7D922B49-EBDF-4197-B92B-A7ED482F7B39

Q38461021-A9E4F290-27EB-4088-8915-B75024859543

Q38461021-B6315781-2171-4339-95B2-1F6D7E52E734

Q38461021-D60BF2FA-98C8-4EBB-B7D3-5582050FA4C3

Q38461021-DFA10135-A4BF-4707-AD66-A893E0B7FE39

P2888

Q38461021-480E6E9A-D792-4688-8B8B-6F16B8F77C73

P304

Q38461021-B0A535D4-2BB3-42F7-AF7A-C603B7B5D4DD

P31

Q38461021-05F80975-92F7-456D-B1AF-9EF1A5F02F25

P356

Q38461021-C5356B44-87E7-4086-B4F2-6D7A9F155A9F

P433

Q38461021-4DC9751A-D443-4F1E-BBEF-37F58441C0BB

P478

Q38461021-56AD79FB-04B9-4D3A-B1E9-9CA84AF15DAA

P50

Q38461021-63316BE7-69AF-4EC8-A5F6-440FE6EC1819

P577

Q38461021-CEF4ADED-5A67-4147-B936-BCFB63EF1401

P5875

Q38461021-92511325-050D-4571-910D-2E15458B659F

P6179

Q38461021-868A5AF9-4892-4E88-9EC3-4BB757F1B4F2

P698

Q38461021-1B67275A-644F-49E4-8BA4-C6A616943F00

P356

MODPATHOL.3880352

P1433

Modern Pathology

P1476

ALK1 and p80 expression and ch ...... ammatory myofibroblastic tumor

@en

P2093

Coffin CM

http://www.w3.org/2001/XMLSchema#string

Griffin CA

http://www.w3.org/2001/XMLSchema#string

Patel A

http://www.w3.org/2001/XMLSchema#string

Perkins S

http://www.w3.org/2001/XMLSchema#string

Perlman E

http://www.w3.org/2001/XMLSchema#string

P2860

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).

Expression of the ALK tyrosine kinase gene in neuroblastoma.

Omental-mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor.

ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.

Clonal changes in inflammatory pseudotumor of the lung: a case report.

P2888

modpathol.3880352

P304

569-576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.3880352

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Kojo Elenitoba-Johnson

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11932554

http://www.w3.org/2001/XMLSchema#string

P6179

1001859466

http://www.w3.org/2001/XMLSchema#string

P698

11406658

http://www.w3.org/2001/XMLSchema#string